🇺🇸 FDA
Patent

US 11759513

Human rotavirus G9P[6] strain and use as a vaccine

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 11759513 (Human rotavirus G9P[6] strain and use as a vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/54, A61K2039/55505